The principal observation in this study is that the hallmark feature linked to PNPLA3-I148M-induced NASH acceleration is ‘metabolic reprogramming’ of the liver with increased TGs and diglycerides, n3 polyunsaturated fatty acids depletion and increased ceramides. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatohepatitis.